Dissociation of antitumor potency from anthracycline cardiotoxicity in a doxorubicin analog. [electronic resource]
- Science (New York, N.Y.) Jun 1985
- 1544-6 p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
0036-8075
10.1126/science.4012308 doi
Animals Antineoplastic Agents Breast Neoplasms--drug therapy Cell Line Chemical Phenomena Chemistry Dose-Response Relationship, Drug Doxorubicin--adverse effects Female Heart--drug effects Humans Isoenzymes L-Lactate Dehydrogenase--analysis Mice Myocardium--enzymology Ovarian Neoplasms--drug therapy Pregnancy